Certified as a venture company originating from Hyogo College of Medicine.

Oct 1, 2025
1 min read

Our company has been certified as a venture company originating from Hyogo College of Medicine. Our CEO, Kenichi Yamahara, is affiliated with Hyogo College of Medicine, and the hospital is the clinical trial site for a physician-initiated clinical trial of comprehensive advanced chronic lower limb ischemia (CLTI) angiogenesis therapy using Injectable cell scaffold (ICS-001).

Comments

Latest Articles

Premo Partner Co., Ltd. wins the top prize in the "MedTech Angels Season 5" acceleration program specializing in medical devices.

Selected for the MEDISO Acceleration Program Direct Flight "San Diego Biotech Week Program supported by KBIC"

At the 25th Annual Meeting of the Japanese Society for Regenerative Medicine, I gave an oral presentation on a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemi...

At the 6th Annual Meeting of the Japanese Society of Foot Care and Podiatric Medicine, we presented on a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemia (CLT...

Selected for JETRO's "J-StarX Biotech Accelerator Program"

LINK-J Pitch Contest "Changing Tomorrow": Special Jury Prize awarded in the Innovation Series showcasing advancements at the Kashiwanoha-Tsukuba Life Science Cluster.

Selected for the second round of research and development grants for fiscal year 2025 from the Mitsubishi UFJ Technology Development Foundation.

A paper detailing the clinical trial of a physician-initiated clinical study using injectable cell scaffold (ICS-001) for comprehensive angiogenesis therapy for severe chronic lower limb ischemia (...

Certified as a venture company originating from Hyogo College of Medicine.

Selected as a recipient company for the 13th term of the Small and Medium Enterprise Infrastructure Development Organization's acceleration program "FASTAR".

Comments

Latest Articles

Premo Partner Co., Ltd. wins the top prize in the "MedTech Angels Season 5" acceleration program specializing in medical devices.

Selected for the MEDISO Acceleration Program Direct Flight "San Diego Biotech Week Program supported by KBIC"

At the 25th Annual Meeting of the Japanese Society for Regenerative Medicine, I gave an oral presentation on a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemi...

At the 6th Annual Meeting of the Japanese Society of Foot Care and Podiatric Medicine, we presented on a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemia (CLT...

Selected for JETRO's "J-StarX Biotech Accelerator Program"

LINK-J Pitch Contest "Changing Tomorrow": Special Jury Prize awarded in the Innovation Series showcasing advancements at the Kashiwanoha-Tsukuba Life Science Cluster.

Selected for the second round of research and development grants for fiscal year 2025 from the Mitsubishi UFJ Technology Development Foundation.

A paper detailing the clinical trial of a physician-initiated clinical study using injectable cell scaffold (ICS-001) for comprehensive angiogenesis therapy for severe chronic lower limb ischemia (...

Certified as a venture company originating from Hyogo College of Medicine.

Selected as a recipient company for the 13th term of the Small and Medium Enterprise Infrastructure Development Organization's acceleration program "FASTAR".

archive